Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$13.36 - $15.43 $45,116 - $52,107
-3,377 Reduced 20.95%
12,746 $181,000
Q3 2023

Nov 09, 2023

BUY
$15.03 - $16.32 $24,543 - $26,650
1,633 Added 11.27%
16,123 $249,000
Q2 2023

Aug 09, 2023

BUY
$15.57 - $17.11 $11,802 - $12,969
758 Added 5.52%
14,490 $227,000
Q1 2023

May 05, 2023

SELL
$15.28 - $16.48 $626 - $675
-41 Reduced 0.3%
13,732 $226,000
Q4 2022

Feb 10, 2023

SELL
$12.42 - $15.62 $1,689 - $2,124
-136 Reduced 0.98%
13,773 $214,000
Q3 2022

Nov 09, 2022

BUY
$12.8 - $28.65 $6,336 - $14,181
495 Added 3.69%
13,909 $180,000
Q2 2022

Aug 11, 2022

BUY
$13.12 - $15.03 $5,864 - $6,718
447 Added 3.45%
13,414 $196,000
Q1 2022

May 09, 2022

BUY
$13.54 - $15.35 $20,553 - $23,301
1,518 Added 13.26%
12,967 $186,000
Q4 2021

Feb 09, 2022

SELL
$13.17 - $16.4 $73,936 - $92,069
-5,614 Reduced 32.9%
11,449 $156,000
Q3 2021

Nov 09, 2021

BUY
$16.3 - $17.26 $423 - $448
26 Added 0.15%
17,063 $279,000
Q2 2021

Aug 06, 2021

SELL
$16.55 - $18.64 $4,716 - $5,312
-285 Reduced 1.65%
17,037 $287,000
Q1 2021

May 10, 2021

BUY
$16.71 - $19.9 $217 - $258
13 Added 0.08%
17,322 $316,000
Q4 2020

Feb 12, 2021

SELL
$15.39 - $18.97 $42,060 - $51,845
-2,733 Reduced 13.64%
17,309 $315,000
Q3 2020

Nov 10, 2020

SELL
$17.1 - $19.19 $9,182 - $10,305
-537 Reduced 2.61%
20,042 $358,000
Q2 2020

Aug 12, 2020

BUY
$14.59 - $19.5 $13,670 - $18,271
937 Added 4.77%
20,579 $369,000
Q1 2020

May 07, 2020

BUY
$13.02 - $20.31 $15,298 - $23,864
1,175 Added 6.36%
19,642 $298,000
Q4 2019

Feb 07, 2020

BUY
$16.88 - $20.83 $67,351 - $83,111
3,990 Added 27.56%
18,467 $364,000
Q3 2019

Nov 06, 2019

BUY
$16.15 - $17.99 $8,834 - $9,840
547 Added 3.93%
14,477 $249,000
Q2 2019

Aug 06, 2019

SELL
$16.58 - $20.49 $38,167 - $47,167
-2,302 Reduced 14.18%
13,930 $247,000
Q1 2019

May 09, 2019

BUY
$16.7 - $21.52 $271,074 - $349,312
16,232 New
16,232 $331,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $44.5B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Checchi Capital Advisers, LLC Portfolio

Follow Checchi Capital Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Checchi Capital Advisers, LLC with notifications on news.